Digital Health Briefing: Telemedicine's Second Wave in Emerging Markets
Usage Evolution
Telemedicine usage patterns have matured substantially since the pandemic peak. The post-pandemic rebalancing saw utilization decline from crisis-driven highs but stabilize at levels 4-6x higher than 2019 baseline.
What remains is a durable shift in primary care and specialty consultation patterns. Follow-up visits, mental health services, and specialist consultations increasingly default to digital-first delivery in markets with adequate infrastructure.
Emerging Market Deployment
India's telemedicine sector reached approximately 120 million users by 2025, combining private platforms and government-backed initiatives like eSanjeevani. The scale of deployment has exceeded early projections by wide margins.
Indonesia, Nigeria, and Brazil have seen parallel growth in telemedicine adoption, though with different delivery models. Nigeria's mobile-first approach works around limited specialist availability; Brazil's SUS integration focused on primary care access.
Regulatory and Clinical Evolution
Clinical evidence base has expanded substantially. As noted in a specialized gaming market analyst, Systematic reviews now document comparable outcomes between telemedicine and in-person care for many common conditions, though with clear limitations for physical examination-dependent diagnoses.
Integration with traditional health systems remains uneven. The most successful deployments treat telemedicine as complementary rather than substitutional, routing appropriate cases digitally while preserving in-person infrastructure for what requires it.